Lipella Pharmaceuticals Inc's Customers Performance

Name: Lipella Pharmaceuticals Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

LIPO

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


LIPO's Source of Revenues		• List of LIPO Customers

for the same period Lipella Pharmaceuticals Inc

• List of LIPO Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Lipella Pharmaceuticals Inc's Comment on Sales, Marketing and Customers

News about Lipella Pharmaceuticals Inc Contracts

Lipella Pharmaceuticals Advances Novel Treatment for Oral Lichen Pla...

Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus: A Promising Step ForwardLipella Pharmaceuticals, a biopharmaceutical company committed to bringing novel therapeutic solutions to unmet medical needs, has announced the completion of the site initiation visit for their Phase 2a clinical trial of LP-310. This trial targets the treatment of Oral Lichen Planus (OLP), a chronic inflammatory condition of the mucous membranes in the mouth. This significant milestone brings renewed hope to patients struggling with this painful and persistent condition. Oral Lichen Planus: A Challenging ConditionOral Lichen Planus is an idiopathic, inflammatory ...

Lipella Pharmaceuticals Takes the Lead in Addressing Hemorrhagic Cystitis with Potential Breakthrough Treatment, LP-10, as FDA Grants Crucial Type C Meeting

Lipella Pharmaceuticals Advances Promising Treatment for Hemorrhagic Cystitis as FDA Grants Type C Meeting Hemorrhagic cystitis, a distressing condition characterized by inflammation and bleeding in the bladder, affects thousands of individuals worldwide. While there are limited treatment options available, pharmaceutical company Lipella Pharmaceuticals has recently made significant strides in developing a potential breakthrough therapy. Lipella recently announced that the U.S. Food and Drug Administration (FDA) has granted them a Type C meeting to discuss their investigational drug, LP-10, aimed at alleviating the symptoms and improving the quality of life for those suffering from this debilitating conditio...

LIPO's Stock Performance relative to it's Customers

LIPO's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Lipella Pharmaceuticals Inc	0.00	0.47	-5.33	16
SUBTOTAL	0.00	0.00	0.00	-

Sources: Lipella Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Lipella Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Lipella Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.